Brightsurf Science News & Current Events

December 11, 2010
Scientist at ASCB to talk cells and novels
Steve Caplan of the University of Nebraska Medical Center in Omaha is coming to the ASCB's 50th Annual Meeting to talk about cellular endocytic trafficking and about novel writing.

Novel imaging technique may reduce lymphedema in breast cancer patients
With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.

Unique needs and outcomes of pregnant women with breast cancer identified
Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group.

'Celldance' spotlights cell biologists' images and videos
Video of fruit fly embryo's sealing shut its new epidermis and a confocal micrograph showing follicle cells of fruit fly egg chamber stained in three colors that resemble a stained glass window will be recognized with first place awards at ASCB's 2010

Higher co-payments increase chance of early discontinuation, inadequate use of breast cancer therapy
A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early-stage breast cancer.

Depression drug may relieve pain from breast cancer treatment, U-M study finds
A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center.

Higher co-payments increase chance of early discontinuation of breast cancer therapy
A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.

Expert analysis of HER2 tests reveals issues with reliability, Mayo Clinic researchers say
Results for testing breast tumors for HER2 proteins and genes is most often straightforward when one piece of tumor (a single tumor block) is analyzed.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.